PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Symbiosis Appoints Joanne Anderson as Chief Commercial Officer

Symbiosis Pharmaceutical Services (Symbiosis), a global contract development and manufacturing organisation (CDMO) specialising in the GMP sterile fill-finish manufa...
Continue Reading →
News

ESTEVE CDMO Commences $15.5 Million Expansion of Chicago Small Molecule API Facility

ESTEVE CDMO, the global pure-play CDMO specializing in high-quality small-molecule APIs and pharmaceutical intermediates, today announced that it had commenced a $15...
Continue Reading →
News

BioDuro and Cenra Launch Joint Venture to Expand Resilient Global API Manufacturing Capacity

BioDuro, a globally trusted Contract Research, Development, and Manufacturing Organization (CRDMO), today announced it has established a joint venture with Cenra API...
Continue Reading →
News

FUJIFILM Biotechnologies Unveils ShunzymeX™ precision purification technology

Launching at the Festival of Biologics, ShunzymeX is designed to streamline process development and accelerate GMP readiness for complex biologics.  FUJIFILM...
Continue Reading →
News

Global pain market presents significant opportunities for novel mechanisms and modalities, says GlobalData

There is a lack of diversity within the current pain market, with non-steroidal anti-inflammatory drugs (NSAIDs) and opioids dominating the market. With 98% of curre...
Continue Reading →
News

Syndex Bio Unveils mcPCR Technology at AGBT 2026 Following $15.5M Seed Financing

mcPCR enables precise copying of DNA methylation during DNA amplification, overcoming a fundamental limitation of PCR, and unlocks new opportunities for sensitive d...
Continue Reading →
News

Epigenica AB Launches EpiFinder™ cNUC: The First Platform to Simultaneously Profile Multiple Histone Marks and DNA Methylation Directly from Circulating Nucleosomes in Plasma and Serum

Epigenica today announces the launch of EpiFinder™ cNUC, a truly unique product for liquid biopsies that significantly expands the capabilities of epigenomic researc...
Continue Reading →
News

SolasCure completes phase II clinical trial, demonstrating accelerated healing with Aurase Wound Gel

Aurase Wound Gel shows 22x faster debridement and 7x faster healing compared to standard of care in sloughy venous leg ulcers, supporting advancement to the next ph...
Continue Reading →
News

ELRIG Appoints Dr Kelly Gray and Dr Elaine Duncan to its Board

·       Strengthens leadership team to support next phase of growth as organisation evolves to meet needs of global drug discovery...
Continue Reading →
News

SPT Labtech to collaborate with Illumina to develop automated platform supporting genomics in decentralized healthcare settings

SPT Labtech to develop an automated sample preparation platform for Illumina to further optimize the efficiency and benefits of genomic workflows in decentralized h...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026